Zhejiang Tailin Bioengineering Co Ltd Market Cap ($331.83 Million)
Market Cap & Net Worth: Zhejiang Tailin Bioengineering Co Ltd (300813)
Zhejiang Tailin Bioengineering Co Ltd market cap. Zhejiang Tailin Bioengineering Co Ltd (SHE:300813) has a market capitalization of $331.83 Million (CN¥2.27 Billion) as of November 8, 2026. Listed on the SHE stock exchange, this China-based company holds position #14027 globally and #4170 in its home market, demonstrating a -1.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Tailin Bioengineering Co Ltd's stock price CN¥18.71 by its total outstanding shares 121199219 (121.20 Million). Also see 300813 cash flow conversion for how efficiently the company converts equity into cash flow.
Zhejiang Tailin Bioengineering Co Ltd Market Cap History (2020–2026)
Zhejiang Tailin Bioengineering Co Ltd market cap history from 2020 to 2026. Data shows growth from $407.47 Million to $331.83 Million (6.41% CAGR). Check Zhejiang Tailin Bioengineering Co Ltd stock price for real-time trading data and today's change.
Zhejiang Tailin Bioengineering Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Tailin Bioengineering Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Zhejiang Tailin Bioengineering Co Ltd (300813) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.30x
Zhejiang Tailin Bioengineering Co Ltd's market cap is 1.30 times its annual revenue
Latest Price to Earnings (P/E) Ratio
26.43x
Zhejiang Tailin Bioengineering Co Ltd's market cap is 26.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $407.47 Million | $200.24 Million | $48.39 Million | 2.03x | 8.42x |
| 2021 | $833.47 Million | $283.25 Million | $63.53 Million | 2.94x | 13.12x |
| 2022 | $623.93 Million | $373.88 Million | $79.69 Million | 1.67x | 7.83x |
| 2023 | $432.74 Million | $269.86 Million | $19.67 Million | 1.60x | 22.00x |
| 2024 | $306.29 Million | $349.00 Million | $13.05 Million | 0.88x | 23.47x |
| 2025 | $435.76 Million | $334.41 Million | $16.49 Million | 1.30x | 26.43x |
Competitor Companies of 300813 by Market Capitalization
Companies near Zhejiang Tailin Bioengineering Co Ltd in the global market cap rankings as of November 8, 2026. Also see 300813 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Zhejiang Tailin Bioengineering Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Zhejiang Tailin Bioengineering Co Ltd (2020–2026)
Market capitalization of Zhejiang Tailin Bioengineering Co Ltd from 2020 to today. Between 2020 and today, Zhejiang Tailin Bioengineering Co Ltd's market cap moved from $407.47 Million to $ 331.83 Million, with a yearly change of 6.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥331.83 Million | -23.85% |
| 2025 | CN¥435.76 Million | +42.27% |
| 2024 | CN¥306.29 Million | -29.22% |
| 2023 | CN¥432.74 Million | -30.64% |
| 2022 | CN¥623.93 Million | -25.14% |
| 2021 | CN¥833.47 Million | +104.55% |
| 2020 | CN¥407.47 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Zhejiang Tailin Bioengineering Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.83 Million USD |
| MoneyControl | $331.83 Million USD |
| MarketWatch | $331.83 Million USD |
| marketcap.company | $331.83 Million USD |
| Reuters | $331.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Tailin Bioengineering Co Ltd
Zhejiang Tailin BioEngineering Co.,Ltd engages in the research and development, production, and sale of microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. The company primarily offers aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technolog… Read more